Events for January 27, 2025 – Pharma Journalist

Cell Therapy Potency Assay Summit Leaderboard

Wednesday, January 8, 2025
About
Advertise
Subscribe
Contact

Pharma Journalist -

Home
News
Drug Research
Clinical Trials
Manufacturing
Information Technology
Packaging & Labeling
Diseases
Resources
Events
Press Releases

Home
Events

Loading view.

Events Search and Views Navigation

Enter Keyword. Search for Events by Keyword.

Event Views Navigation

List
Month
Day

Select date.

All Day

January 27 - January 29

The 3rd Medical Device Software Development Summit Europe

H4 Hotel Munchen Messe Konrad-Zuse-Platz 14, Munchen

Integrating Expertise from Software Development, Quality Assurance, Regulatory Affairs, & Product Teams to Drive Innovation in Alignment with Global Regulatory Guidelines, AI & ML Enabled Software, Cybersecurity, & Agile Methodologies: […]

Previous Day
Next Day

Google Calendar
iCalendar
Outlook 365
Outlook Live
Export .ics file
Export Outlook .ics file

About Us

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts

European Commission (EC) Extends the Approval of Evkeeza (evinacumab) to Children as Young as 6-months Old with Homozygous Familial Hypercholesterolemia (HoFH)
GSK’s Nucala (mepolizumab) approved in China for treatment of adults with chronic rhinosinusitis with nasal polyps
LPOXY Therapeutics, Inc. Acquires Key Assets from Xeno Biosciences Inc. to Advance C. difficile Prevention Therapy
Brii Bio Announces Signing of Asset Purchase Agreements Acquiring BRII-179 IP Rights and Completed Patient Enrollment for ENRICH Study
China’s NMPA Approves VYLOY (zolbetuximab) for First-Line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Industry Reports

AbbVie Completes Acquisition of ImmunoGen

Sanofi to acquire Inhibrx, Inc., adding potential…

Esperion and Daiichi Sankyo Europe Announce $125 Million…

Avistone Biotechnology Announces Closing of Series B…

Apollo Therapeutics Closes $226.5 Million Series C…

5th Genome Editing Therapeutics Summit is only 3 weeks…

Celebrating More than a Decade of Excellence at the World…

Final Week to Save $350: Accelerate Your Gene Editing…

An Interview with Jeffrey Cehelsky, Intellia Therapeutics

Hottest Gene Editing Events Causing Waves in 2024

About
Advertise
Subscribe
Contact

© 2025 - Pharma Journalist. All Rights Reserved.

Pharma Journalist is a product of

Sign in

Welcome, Login to your account.

Forget password? Remember me

Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok Learn More